Sign in

Publications

Search in 13054 publications:

Reset RSS
Time frame
13054 Publication(s)
Jun 14, 2018
Pseudolymphomatous Reaction to Red Tattoo Pigment
Saulite I, Pekar-Lukacs A, Kerl K, Cozzio A, Hoetzenecker W, Guenova E. Pseudolymphomatous Reaction to Red Tattoo Pigment. Case Rep Dermatol 2018; 10:162-168.
Jun 14, 2018
Pseudolymphomatous Reaction to Red Tattoo Pigment
Jun 14, 2018

Case Rep Dermatol 2018; 10:162-168

Saulite Ieva, Pekar-Lukacs Agnes, Kerl Katrin, Cozzio Antonio, Hoetzenecker Wolfram, Guenova Emmanuella

more
Jun 13, 2018
Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
Steinmann E, Brunner-La Rocca H, Maeder M, Kaufmann B, Pfisterer M, Rickenbacher P. Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?. Eur J Intern Med 2018
Jun 13, 2018
Is the clinical presentation of chronic heart failure different in elderly versus younger patients and those with preserved versus reduced ejection fraction?
Jun 13, 2018

Eur J Intern Med 2018

Steinmann Eva, Brunner-La Rocca Hans-Peter, Maeder Micha, Kaufmann Beat A, Pfisterer Matthias, Rickenbacher Peter

more
Jun 12, 2018
What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?. J Diabetes Complicat 2018; 32:911-915.
Jun 12, 2018
What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Jun 12, 2018

J Diabetes Complicat 2018; 32:911-915

Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M

more
Jun 12, 2018
The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Herman W, Braffett B, Kuo S, Lee J, Brändle M, Jacobson A, Prosser L, Lachin J. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC). J Diabetes Complicat 2018; 32:934-939.
Jun 12, 2018
The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC)
Jun 12, 2018

J Diabetes Complicat 2018; 32:934-939

Herman William H, Braffett Barbara H, Kuo Shihchen, Lee Joyce M, Brändle Michael, Jacobson Alan M, Prosser Lisa A, Lachin John M

more
Jun 12, 2018
Irisprint-Kontaktlinsen: Ein Überblick aus der Augenklinik Basel
Beuschel R, Todorova M. Irisprint-Kontaktlinsen: Ein Überblick aus der Augenklinik Basel. Focus 2018:42-44.
Jun 12, 2018
Irisprint-Kontaktlinsen: Ein Überblick aus der Augenklinik Basel
Jun 12, 2018

Focus 2018:42-44

Beuschel Ralf, Todorova Margarita

more
Jun 12, 2018
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Baldauf M, Gerke J, Orth M, Dallmayer M, Baumhoer D, de Alava E, Hartmann W, Kirchner T, Grünewald T. Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?. Mod Pathol 2018; 31:997-999.
Jun 12, 2018
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Jun 12, 2018

Mod Pathol 2018; 31:997-999

Baldauf Michaela, Gerke Julia S, Orth Martin F, Dallmayer Marlene, Baumhoer Daniel, de Alava Enrique, Hartmann Wolfgang, Kirchner Thomas, Grünewald Thomas G P

more
Jun 8, 2018
Blackburne-Peel ratio predicts patients' outcomes after total knee arthroplasty
Behrend H, Graulich T, Gerlach R, Spross C, Ladurner A. Blackburne-Peel ratio predicts patients' outcomes after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2018
Jun 8, 2018
Blackburne-Peel ratio predicts patients' outcomes after total knee arthroplasty
Jun 8, 2018

Knee Surg Sports Traumatol Arthrosc 2018

Behrend Henrik, Graulich Tilman, Gerlach Rene, Spross Christian, Ladurner Andreas

more
Jun 8, 2018
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial
Weber W, Sarlos D, Leo C, Canonica C, Gabriel N, Zeindler J, Cassoly E, Andrieu C, Soysal S, Ruhstaller T, Fehr P, Knauer M, Pioch V, Güth U, Hess T, Tausch C, Hayoz S, Fehr M, Ribi K, Hawle H, Lupatsch J, Matter-Walstra K, Chiesa F, Dedes K, Berclaz G, Lelièvre L, Swiss Group for Clinical Cancer Research (SAKK). Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial. Ann Surg Oncol 2018; 25:2632-2640.
Jun 8, 2018
Impact of a Surgical Sealing Patch on Lymphatic Drainage After Axillary Dissection for Breast Cancer: The SAKK 23/13 Multicenter Randomized Phase III Trial
Jun 8, 2018

Ann Surg Oncol 2018; 25:2632-2640

Weber Walter Paul, Sarlos Dimitri, Leo Cornelia, Canonica Claudia, Gabriel Natalie, Zeindler Jasmin, Cassoly Estelle, Andrieu Christiane, Soysal Savas Deniz, Ruhstaller Thomas, Fehr Peter Martin, Knauer Michael, Pioch Verena, Güth Uwe, Hess Thomas, Tausch Christoph, Hayoz Stefanie, Fehr Mathias Konrad, Ribi Karin, Hawle Hanne, Lupatsch Judith Eva, Matter-Walstra Klazien, Chiesa Federica, Dedes Konstantin Johannes, Berclaz Gilles, Lelièvre Loic, Swiss Group for Clinical Cancer Research (SAKK)

more
Jun 8, 2018
Haben deutsche customised Wachstumskurven Vorteile gegenüber Kurven des Geburtsgewichts nach Intergrowth und Voigt?
Arabin B, Kinkel J, Gardosi J, Pecks U, Timmesfeld N (2018). Haben deutsche customised Wachstumskurven Vorteile gegenüber Kurven des Geburtsgewichts nach Intergrowth und Voigt?.
Jun 8, 2018
Haben deutsche customised Wachstumskurven Vorteile gegenüber Kurven des Geburtsgewichts nach Intergrowth und Voigt?
Jun 8, 2018

18. Kongress der DGPGM 2018

Arabin B, Kinkel Janis, Gardosi J, Pecks U, Timmesfeld N

more
Jun 8, 2018
High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis
Köhn N, Blazer D, Schmied B, Gloor B, Candinas D, Nussbaum D, Tsai C, Warschkow R, Maubach J, Worni M. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford) 2018; 20:1073-1081.
Jun 8, 2018
High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis
Jun 8, 2018

HPB (Oxford) 2018; 20:1073-1081

Köhn Nastassja, Blazer Dan G, Schmied Bruno, Gloor Beat, Candinas Daniel, Nussbaum Daniel P, Tsai Catherine, Warschkow Rene, Maubach Johannes, Worni Mathias

more
Jun 7, 2018
Mütterlicher Einfluss auf das Geburtsgewicht und die Länge bei Geburt von 2000-2015 anhand der Perinatalerhebung in Hessen zwischen 2000 und 2015
Kinkel J, Noever K, Timmesfeld N, Misselwitz B, Arabin B (2018). Mütterlicher Einfluss auf das Geburtsgewicht und die Länge bei Geburt von 2000-2015 anhand der Perinatalerhebung in Hessen zwischen 2000 und 2015.
Jun 7, 2018
Mütterlicher Einfluss auf das Geburtsgewicht und die Länge bei Geburt von 2000-2015 anhand der Perinatalerhebung in Hessen zwischen 2000 und 2015
Jun 7, 2018

18. Kongress der DGPGM 2018

Kinkel Janis, Noever K, Timmesfeld N, Misselwitz B, Arabin B

more
Jun 7, 2018
The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis
Ackermann C, Gueller U, Jochum W, Schmied B, Warschkow R. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis. Int J Colorectal Dis 2018
Jun 7, 2018
The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis
Jun 7, 2018

Int J Colorectal Dis 2018

Ackermann Christoph Jakob, Gueller Ulrich, Jochum Wolfram, Schmied Bruno, Warschkow Rene

more
Jun 7, 2018
Medical Freezing - Nicht nur vor Chemotherapie
Hungerbuehler V (2018). Medical Freezing - Nicht nur vor Chemotherapie. Presented at: Symposium Medical Freezing - Social Freezing, Universitätsspital Zürich
Jun 7, 2018
Medical Freezing - Nicht nur vor Chemotherapie
Jun 7, 2018

Symposium Medical Freezing - Social Freezing

Hungerbuehler Vera

more
Jun 6, 2018
Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort
Mueller R, Kaegi T, Haile S, Schulze-Koops H, Schiff M, von Kempis J. Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort. RMD Open 2018; 4:e000673.
Jun 6, 2018
Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort
Jun 6, 2018

RMD Open 2018; 4:e000673

Mueller Ruediger B, Kaegi Toni, Haile Sarah R, Schulze-Koops Hendrik, Schiff Michael, von Kempis Johannes

more
Jun 4, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Gillison M, Blumenschein G, Fayette J, Guigay J, Colevas A, Licitra L, Harrington K, Kasper S, Vokes E, Even C, Worden F, Saba N, Iglesias Docampo L, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Li L, Ferris R. CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. Oncologist 2018; 23:1079-1082.
Jun 4, 2018
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Jun 4, 2018

Oncologist 2018; 23:1079-1082

Gillison Maura L, Blumenschein George, Fayette Jerome, Guigay Joel, Colevas A Dimitrios, Licitra Lisa, Harrington Kevin J, Kasper Stefan, Vokes Everett, Even Caroline, Worden Francis, Saba Nabil F, Iglesias Docampo Lara Carmen, Haddad Robert, Rordorf Tamara, Kiyota Naomi, Tahara Makoto, Monga Manish, Lynch Mark, Li Li, Ferris Robert L

more
Jun 4, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Francis P, Pavesi L, Ruhstaller T, Davidson N, Coleman R, Debled M, Buchholz S, Ingle J, Winer E, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates A, Gelber R, Goldhirsch A, Regan M, Climent M, Spazzapan S, Puglisi F, Pagani O, Fleming G, Walley B, Colleoni M, Láng I, Gomez H, Tondini C, Ciruelos E, Burstein H, Bonnefoi H, Bellet M, Martino S, Geyer C, Goetz M, Stearns V, Pinotti G, SOFT and TEXT Investigators and the International Breast Cancer Study Group. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. N Engl J Med 2018; 379:122-137.
Jun 4, 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Jun 4, 2018

N Engl J Med 2018; 379:122-137

Francis Prudence A, Pavesi Lorenzo, Ruhstaller Thomas, Davidson Nancy E, Coleman Robert, Debled Marc, Buchholz Stefan, Ingle James N, Winer Eric P, Maibach Rudolf, Rabaglio-Poretti Manuela, Ruepp Barbara, Di Leo Angelo, Coates Alan S, Gelber Richard D, Goldhirsch Aron, Regan Meredith M, Climent Miguel A, Spazzapan Simon, Puglisi Fabio, Pagani Olivia, Fleming Gini F, Walley Barbara A, Colleoni Marco, Láng István, Gomez Henry L, Tondini Carlo, Ciruelos Eva, Burstein Harold J, Bonnefoi Hervé R, Bellet Meritxell, Martino Silvana, Geyer Charles E, Goetz Matthew P, Stearns Vered, Pinotti Graziella, SOFT and TEXT Investigators and the International Breast Cancer Study Group

more
Jun 1, 2018
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Weyerbrock A. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro Oncol 2018; 2018 Jun
Jun 1, 2018
Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma
Jun 1, 2018

Neuro Oncol 2018; 2018 Jun

Weyerbrock Astrid

more
Jun 1, 2018
Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer
Siano M, Jarisch N, Jörger M, Espeli V. Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer. Anticancer Res 2018; 38:3725-3729.
Jun 1, 2018
Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer
Jun 1, 2018

Anticancer Res 2018; 38:3725-3729

Siano Marco, Jarisch Nadine, Jörger Markus, Espeli Vittoria

more
Jun 1, 2018
Potato consumption and risk of pancreatic cancer in the HELGA cohort
Åsli L, Braaten T, Olsen A, Tjønneland A, Overvad K, Nilsson L, Renström F, Lund E, Skeie G. Potato consumption and risk of pancreatic cancer in the HELGA cohort. Br J Nutr 2018; 119:1408-1415.
Jun 1, 2018
Potato consumption and risk of pancreatic cancer in the HELGA cohort
Jun 1, 2018

Br J Nutr 2018; 119:1408-1415

Åsli Lene A, Braaten Tonje, Olsen Anja, Tjønneland Anne, Overvad Kim, Nilsson Lena Maria, Renström Frida, Lund Eiliv, Skeie Guri

more
Jun 1, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
Ruhstaller T, Mingrone W, Montemurro M, Girschikofsky M, Schmidt S, Bitzer M, Bedenne L, Brauchli P, Stahl M, Hess V, Mariette C, Hawle H, Thuss-Patience P, Hayoz S, Schacher S, Knorrenschild J, Schnider A, Plasswilm L, Budach W, Eisterer W, Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft Medikamentöse Tumortherapie’ (AGMT), and the Fédération Francophone de Cancérologie Digestive (FFCD)/Fédération de Recherche en Ch. Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08). Ann Oncol 2018; 29:1386-1393.
Jun 1, 2018
Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)
Jun 1, 2018

Ann Oncol 2018; 29:1386-1393

Ruhstaller Thomas, Mingrone W, Montemurro M, Girschikofsky M, Schmidt S C, Bitzer M, Bedenne L, Brauchli P, Stahl M, Hess V, Mariette C, Hawle H, Thuss-Patience P, Hayoz S, Schacher S, Knorrenschild J R, Schnider A, Plasswilm L, Budach W, Eisterer W, Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft Medikamentöse Tumortherapie’ (AGMT), and the Fédération Francophone de Cancérologie Digestive (FFCD)/Fédération de Recherche en Ch

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy